Join to View Full Profile
325 9th AveSeattle, WA 98104
Phone+1 206-520-5000
Dr. Su is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount SinaiClass of 2015
Certifications & Licensure
WA State Medical License 2022 - 2026
MI State Medical License 2019 - 2023
NY State Medical License 2018 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- HSR25-184: Association of Chimeric Antigen Receptor T-Cell Therapy and Social Vulnerability Index: A National View of Care Delivery Patterns.Christopher T Su, Emisa Nategh, Alireza Boloori
Journal of the National Comprehensive Cancer Network. 2025-03-28 - 4 citationsMitigating time toxicity in lymphoma and multiple myeloma.Mengyang Di, Christopher T Su, Andrew J Cowan, Ajay K Gopal, Rahul Banerjee
Leukemia & Lymphoma. 2024-10-01 - 6 citationsFinancial Toxicity, Time Toxicity, and Quality of Life in Multiple Myeloma.Rahul Banerjee, Andrew J Cowan, Marivel Ortega, Constance Missimer, Paul A Carpenter
Clinical Lymphoma, Myeloma & Leukemia. 2024-07-01
Journal Articles
- Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients with Renal Cell CarcinomaPraful Ravi, Charlene Mantia, Christopher Su, Neeraj Agarwal, Yousef Zakharia, Rana R Mckay, Vivek Narayan, Ajjai Alva, Bradley A Mcgregor, David F Mcdermott, Toni K C..., JAMA Oncology
Authored Content
- Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients with Renal Cell CarcinomaMay 2020
- Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients with Renal Cell CarcinomaMay 2020
Press Mentions
ACA Eases Patient Financial Responsibility for Cancer SurvivorsJuly 19th, 2021- Financial Barriers Fell for Some Cancer Survivors After Affordable Care ActJuly 13th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
